ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

UT System Chancellor to Travel to MD Anderson After Faculty Senate Survey Finds Plunging Morale

September 6, 2013

Funding Opportunities (8-page issue).

May 23, 2003

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Lung Cancer Mortality Begins to decline Among Under 55 Group

April 6, 1990

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991